| Business Summary | | Bio-Rad
Laboratories,
Inc.
manufactures
and
supplies
the
life
science
research,
analytical
chemistry
and
healthcare
markets
with
a
broad
range
of
products
and
systems
used
to
separate
complex
chemical
and
biological
materials,
and
to
identify,
analyze
and
purify
their
components.
The
Company
operates
in
two
industry
segments,
designated
Life
Science
and
Clinical
Diagnostics.
The
Company
focuses
on
selected
segments
of
the
life
science
market,
laboratory
devices,
biomaterials,
imaging
products
and
microscopy
systems.
The
clinical
diagnostics
industry
encompasses
a
broad
array
of
technologies
incorporated
into
a
variety
of
tests
used
to
detect,
identify
and
quantify
substances
in
blood
or
other
bodily
fluids
and
tissues. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Bio-Rad
manufactures
and
supplies
the
life
science,
analytical
chemistry
and
healthcare
markets
with
a
broad
range
of
products
and
systems
used
to
separate
complex
chemical
and
biological
materials,
and
to
identify,
analyze
and
purify
their
components.
For
the
six
months
ended
6/01,
sales
rose
7%
to
$398
million.
Net
income
rose
from
$8
million
to
$20.1
million.
Revenues
reflect
higher
demand
from
proteomic
and
genomic
researchers.
Earnings
also
reflect
improved
gross
margins. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000
Compensation | | Pay | Exer | |
| David Schwartz, 76 Chairman,
Pres, CEO | $1.4M | $6.8M | James Bennett, 72 Exec.
VP and COO | 727K | 5.7M | Thomas Chesterman, 41 VP,
CFO | -- | -- | Norman Schwartz, 51 VP | 391K | -- | Rello Cristea, 57 VP
and Group Mang. of Analytical Instruments | -- | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|